Free Content


Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer‐prone genodermatoses

Commentary or Editorial available

Plain Language Summary available

Article first published online: 16 Apr 2019
DOI: 10.1111/bjd.17698

Comment on this article



Recessive dystrophic epidermolysis bullosa ( RDEB ), Kindler syndrome ( KS ) and xeroderma pigmentosum complementation group C ( XPC ) are three cancer‐prone genodermatoses whose causal genetic mutations cannot fully explain, on their own, the array of associated phenotypic manifestations. Recent evidence highlights the role of the stromal microenvironment in the pathology of these disorders.


To investigate, by means of comparative gene expression analysis, the role played by dermal fibroblasts in the pathogenesis of RDEB , KS and XPC .


We conducted RNA ‐Seq analysis, which included a thorough examination of the differentially expressed genes, a functional enrichment analysis and a description of affected signalling circuits. Transcriptomic data were validated at the protein level in cell cultures, serum samples and skin biopsies.


Interdisease comparisons against control fibroblasts revealed a unifying signature of 186 differentially expressed genes and four signalling pathways in the three genodermatoses. Remarkably, some of the uncovered expression changes suggest a synthetic fibroblast phenotype characterized by the aberrant expression of extracellular matrix ( ECM ) proteins. Western blot and immunofluorescence in situ analyses validated the RNA ‐Seq data. In addition, enzyme‐linked immunosorbent assay revealed increased circulating levels of periostin in patients with RDEB .


Our results suggest that the different causal genetic defects converge into common changes in gene expression, possibly due to injury‐sensitive events. These, in turn, trigger a cascade of reactions involving abnormal ECM deposition and underexpression of antioxidant enzymes. The elucidated expression signature provides new potential biomarkers and common therapeutic targets in RDEB , XPC and KS .

What’s already known about this topic?

Recessive dystrophic epidermolysis bullosa ( RDEB ), Kindler syndrome ( KS ) and xeroderma pigmentosum complementation group C ( XPC ) are three genodermatoses with high predisposition to cancer development. Although their causal genetic mutations mainly affect epithelia, the dermal microenvironment likely contributes to the physiopathology of these disorders.

What does this study add?

We disclose a large overlapping transcription profile between XPC, KS and RDEB fibroblasts that points towards an activated phenotype with high matrix‐synthetic capacity. This common signature seems to be independent of the primary causal deficiency, but reflects an underlying derangement of the extracellular matrix via transforming growth factor‐β signalling activation and oxidative state imbalance.

What is the translational message?

This study broadens the current knowledge about the pathology of these diseases and highlights new targets and biomarkers for effective therapeutic intervention. It is suggested that high levels of circulating periostin could represent a potential biomarker in RDEB.

Read moreRead more (PDF)

Supporting Information

bjd17698-sup-0008-PowerpointS1.pptxPowerpoint S1. Journal Club Slide Set.

Share this article




If you want to submit a letter for publication rather than comment on an article please submit through Scholar One:

There are no comments for this article yet.

Recent Tweets


13 Nov 2019

Find out how changing immunosuppressive treatment practices have impacted SCC and BCC cancer risk in organ transplant recipients at #SCC #BCC #organtransplant #epidemiology


13 Nov 2019

RT The British Association of Dermatologists @HealthySkin4All: We are very excited to be planning the launch of a new open access journal, for which we are now looking for an Editor-in-Chief. Full details and information on how to apply for this role can be found here: @BrJDermatol @ced_wiley


13 Nov 2019

RT Dr Katie Farquhar @katiefarquhar: Very interesting article looking at skin cancer trends in transplant recipients from @BrJDermatol


12 Nov 2019

Why has there been a significant reduction in the incidences of both SCC and BCC in organ transplant recipients over the past two decades? #SCC #BCC #organtransplant #epidemiology


12 Nov 2019

RT The British Association of Dermatologists @HealthySkin4All: There is a need for more economic studies which look at the costs and effectiveness of two or more eczema treatments. These types of studies help inform how healthcare resources are used. @BrJDermatol @Wiley_Health @eczemasociety


11 Nov 2019

Join the discussion regarding the definition and clinical implications of palmoplantar pustulosis at #psoriasis #commentary